Integrating The Digital And Physical Supply Chain In Clinical Trials
The pharmaceutical industry’s current drug development system is “in crisis and unsustainable” according to the Clinical Trials Transformation Initiative (CTTI), a public-private partnership in the US to improve the quality and efficiency of clinical trials. The organization has, over the past few years, issued multiple sound recommendations for sponsors and Contract Research Organizations (CROs) on a range of trial processes—from recruitment planning to data monitoring. Meanwhile, sponsors and CROs are actively pursuing various trial innovations that can ultimately lead to a competitive advantage in the market. Yet, there is a frequent source of inefficiency in clinical trial operations that is often overlooked: the lack of coordination between the digital and the physical supply chain of drug delivery to trial sites. Here, we will discuss the costs and risks of taking a fragmented approach to managing and moving drug supplies and will explain how those risks can be mitigated.
Source: Clinical Leader
